Products

IFF Pharma Solutions

4 Products found on IFF Pharma Solutions  in Base Fluids, Glidants & Lubricants

With SDS
With TDS
POLYOX™ WSR - 301 FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 301 FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 301 FP NF Grade characterized by its off-white color, serves as a binder and thickener in cosmetic formulations. It is available in powder form and exhibits water solubility. Its versatility extends to various dosage forms including abuse deterrent tablets & capsules, gels, and osmotic pump tablets.
POLYOX™ WSR - N12K NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - N12K NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - N12K NF Grade is an off-white powder with water-soluble properties. It's used as a binder and thickener in cleaning products and pharmaceuticals. Its applications include gels, osmotic pump tablets, and regular tablets, and it's manufactured using direct compression technology. Additionally, it serves as a controlled release agent.
POLYOX™ WSR - 1105 NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 1105 NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 1105 NF Grade an off-white powder, serves as a binder and thickener in cleaning agents. It is available in powder form and is water-soluble, making it suitable for use in gels and osmotic pump tablets.
POLYOX™ WSR - 303 NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 303 NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 303 NF Grade with its off-white powdered form, serves various functions in cleaning ingredients, acting as a binder and thickener. It finds application in diverse dosage forms such as gels, osmotic pump tablets, and conventional tablets, leveraging its water solubility and facilitating controlled release in pharmaceutical and nutraceutical formulations, manufactured through direct compression technology.